Cargando…

IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy

IgG4-related disease (IgG4-RD) is a recently recognized disorder, characterized by elevated serum IgG4 concentrations, dense tissue infiltration of IgG4-positive plasma cells and storiform fibrosis. Treatment is usually based on steroids, however, relapses and long-term adverse effects are frequent....

Descripción completa

Detalles Bibliográficos
Autores principales:	Quattrocchio, Giacomo, Barreca, Antonella, Demarchi, Andrea, Solfietti, Laura, Beltrame, Giulietta, Fenoglio, Roberta, Ferro, Michela, Mesiano, Paola, Murgia, Stefano, Del Vecchio, Giulio, Massara, Carlo, Rollino, Cristiana, Roccatello, Dario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940417/ https://www.ncbi.nlm.nih.gov/pubmed/29765543 http://dx.doi.org/10.18632/oncotarget.25095

Ejemplares similares

Long-term effects of intensive B cell depletion therapy in severe cases of IgG4-related disease with renal involvement
por: Quattrocchio, Giacomo, et al.
Publicado: (2020)

Renal biopsy in patients over 75: 131 cases
por: Rollino, Cristiana, et al.
Publicado: (2014)

Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome
por: Fenoglio, Roberta, et al.
Publicado: (2018)

Monoclonal Gammopathy of Renal Significance: Clinical and Histological Efficacy of a Bortezomib-Based Regimen
por: Quattrocchio, Giacomo, et al.
Publicado: (2020)

Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy
por: Roccatello, Dario, et al.
Publicado: (2022)

The steroid-sparing effects of a mycophenolate mofetil-based regimen in the management of immunoglobulin A nephropathy in patients with histologically active lesions: A comparison with a control cohort receiving conventional therapy
por: Roccatello, Dario, et al.
Publicado: (2023)

Recognizing the new disorder “idiopathic hypocryoglobulinaemia” in patients with previously unidentified clinical conditions
por: Roccatello, Dario, et al.
Publicado: (2022)

Renal involvement as a unique manifestation of hemophagocytic syndrome
por: Roccatello, Dario, et al.
Publicado: (2022)

The need for kidney biopsy in the management of side effects of target and immunotherapy
por: Fenoglio, Roberta, et al.
Publicado: (2023)

Semi-selective plasma filtration applied to the treatment of acquired thrombotic thrombocytopenic purpura following bnt162b2 administration
por: Fenoglio, Roberta, et al.
Publicado: (2022)

A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy
por: Roccatello, Dario, et al.
Publicado: (2021)

The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents
por: Roccatello, Dario, et al.
Publicado: (2017)

CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond
por: Roccatello, Dario, et al.
Publicado: (2020)

Rituximab-induced IgG hypogammaglobulinemia in children with nephrotic syndrome and normal pre-treatment IgG values
por: Marzuillo, Pierluigi, et al.
Publicado: (2019)

Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis
por: Wallwork, Rachel, et al.
Publicado: (2018)

Reformatting Rituximab into Human IgG2 and IgG4 Isotypes Dramatically Improves Apoptosis Induction In Vitro
por: Könitzer, Jennifer D., et al.
Publicado: (2015)

Non HCV-Related Mixed Cryoglobulinemic Vasculitis With Biopsy-Proven Renal Involvement: The Effects of Rituximab
por: Fenoglio, Roberta, et al.
Publicado: (2022)

IgG N-glycosylation from Patients with Pemphigus Treated with Rituximab
por: Font, Guillaume, et al.
Publicado: (2022)

Successful treatment of IgG4‐related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab
por: Seegobin, Karan, et al.
Publicado: (2021)

Refractory IgG4-related intracranial hypertrophic pachymeningitis responded to rituximab
por: Liao, Bing, et al.
Publicado: (2014)

IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia
por: Schmidt, David E., et al.
Publicado: (2020)

Immunologic overlap in a case of linear IgG/IgA bullous dermatosis responsive to rituximab
por: Nedosekin, Dmitry, et al.
Publicado: (2021)

Rituximab treatment for isolated IgG4-related hypophysitis in a teenage female
por: Bullock, Danielle R, et al.
Publicado: (2018)

Association of Systemic Lupus Erythematosus With Decreased Immunosuppressive Potential of the IgG Glycome
por: Vučković, Frano, et al.
Publicado: (2015)

Regression of IgG4-related coronary arteritis and aortitis with immunosuppressive therapy
por: Tse, Yiu-Hei, et al.
Publicado: (2022)

Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience
por: Roccatello, Dario, et al.
Publicado: (2020)

Rituximab for the Treatment of IgG4-Related Tubulointerstitial Nephritis: Case Report and Review of the Literature
por: McMahon, Blaithin A., et al.
Publicado: (2015)

Proliferative glomerulonephritis with monoclonal IgG deposits in two kidney allografts successfully treated with rituximab
por: Merhi, Basma, et al.
Publicado: (2017)

A Case Series of Patients with Isolated IgG4-related Hypophysitis Treated with Rituximab
por: Boharoon, Hessa, et al.
Publicado: (2020)

Pulmonary IgG4‐related disease with favourable response to rituximab: A case report
por: Muller, Romain, et al.
Publicado: (2022)

A Case of Recurrent Proliferative Glomerulonephritis with Monoclonal IgG Deposits after Kidney Transplant Treated with Plasmapheresis
por: Ranghino, Andrea, et al.
Publicado: (2012)

Immunosuppressant treatment for IgG4-related sclerosing cholangitis: A case report
por: Kim, Jong-Sun, et al.
Publicado: (2021)

Focal segmental glomerular sclerosis can be effectively treated using an intensive B-cell depletion therapy
por: Roccatello, Dario, et al.
Publicado: (2022)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

Targeted Immunotherapy with Rituximab Leads to a Transient Alteration of the IgG Autoantibody Profile in Pemphigus Vulgaris
por: Müller, Ralf, et al.
Publicado: (2010)

Rituximab: Humoral immune defect and negative seroconversion IgG-spike 1 test: case report
Publicado: (2022)

Progression to End-Stage Renal Disease Due to IgG4-Related Nephritis Refractory to Rituximab
por: Nguyen, Tien, et al.
Publicado: (2023)

The “4 plus 2” rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study
por: Roccatello, Dario, et al.
Publicado: (2017)

Listeria monocytogenes Meningitis in an Immunosuppressed Patient with Autoimmune Hepatitis and IgG4 Subclass Deficiency
por: Gaini, Shahin
Publicado: (2015)

Immunosuppressive therapy with rituximab in common variable immunodeficiency
por: Pecoraro, Antonio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d490q4er17dm6n6v5lbgs0fnsr